Dominic Cosgrove

Person

Omaha, NE, US

People

Patents Grantslast 30 patents

Information Patent Grant
RAC1 inhibitors for the treatment of Alport glomerular disease
- Patent number 10,545,134
- Issue date Jan 28, 2020
- Father Flanagan's Boys' Home
- Dominic Cosgrove
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RAC1 inhibitors for the treatment of alport glomerular disease
- Patent number 9,719,981
- Issue date Aug 1, 2017
- Father Flanagan's Boys' Home
- Dominic Cosgrove
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inducible ligand for α1β1 integrin and uses
- Patent number 7,662,382
- Issue date Feb 16, 2010
- Boys Town National Research Hospital
- Dominic Cosgrove
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inducible ligand for α1β1 integrin and uses
- Patent number 7,348,002
- Issue date Mar 25, 2008
- Boys Town National Research Hospital
- Dominic Cosgrove
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of α1β1 integrin receptor inhibitors and TGF-&#x0...
- Patent number 6,492,325
- Issue date Dec 10, 2002
- Boys Town National Research Hospital
- Dominic Cosgrove
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Genetically engineered mice containing alterations in the MHC class...
- Patent number 5,644,065
- Issue date Jul 1, 1997
- Bristol-Myers Squibb Company
- Christophe Benoist
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
COMBINATION THERAPY FOR ALPORT RENAL DISEASE
- Publication number 20230374141
- Publication date Nov 23, 2023
- Father Flanagan's Boys' Home doing business as Boys Town National Research Ho...
- Dominic Cosgrove
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEUTRALIZING ANTIBODIES TO HUMAN ENDOTHELIN
- Publication number 20220195034
- Publication date Jun 23, 2022
- Father Flanagan's Boys' Home doing business as Boys Town National Research Ho...
- Dominic Cosgrove
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RAC1 INHIBITORS FOR THE TREATMENT OF ALPORT GLOMERULAR DISEASE
- Publication number 20170285005
- Publication date Oct 5, 2017
- Father Flanagan's Boys' Home doing business as Boys Town National Research Ho...
- Dominic Cosgrove
- G01 - MEASURING TESTING
Information Patent Application
RAC1 INHIBITORS FOR THE TREATMENT OF ALPORT GLOMERULAR DISEASE
- Publication number 20150175695
- Publication date Jun 25, 2015
- Father Flanagan's Boys' Home doing business as Boys Town National Research Ho...
- Dominic Cosgrove
- G01 - MEASURING TESTING
Information Patent Application
Inducible ligand for alpha1beta1 integrin and uses
- Publication number 20080227121
- Publication date Sep 18, 2008
- BOYS TOWN NATIONAL RESEARCH HOSPITAL
- Dominic Cosgrove
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Treatment of Golmerular Basement Membrane Disease Involving Matrix...
- Publication number 20080187508
- Publication date Aug 7, 2008
- BOYS TOWN NATIONAL RESEARCH HOSPITAL
- Dominic E. Cosgrove
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Inducible ligand for alpha1beta1 integrin and uses
- Publication number 20040253241
- Publication date Dec 16, 2004
- BOYS TOWN NATIONAL RESEARCH HOSPITAL
- Dominic Cosgrove
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Immunodiagnostic determination of usher syndrome type IIA
- Publication number 20020098516
- Publication date Jul 25, 2002
- BOYSTOWN NATIONAL RESEARCH HOSPITAL
- Dominic E. Cosgrove
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Use of alpha1beta1 integrin receptor inhibitors and TGF-beta1 inhib...
- Publication number 20020094956
- Publication date Jul 18, 2002
- BOYS TOWN NATIONAL RESEARCH HOSPITAL
- Dominic Cosgrove
- C07 - ORGANIC CHEMISTRY

Dominic Cosgrove

Person

Patents Grantslast 30 patents

RAC1 inhibitors for the treatment of Alport glomerular disease

RAC1 inhibitors for the treatment of alport glomerular disease

Inducible ligand for α1β1 integrin and uses

Inducible ligand for α1β1 integrin and uses

Use of &#x03B1;1&#x03B2;1 integrin receptor inhibitors and TGF-&#x0...

Genetically engineered mice containing alterations in the MHC class...

Patents Applicationslast 30 patents

COMBINATION THERAPY FOR ALPORT RENAL DISEASE

NEUTRALIZING ANTIBODIES TO HUMAN ENDOTHELIN

RAC1 INHIBITORS FOR THE TREATMENT OF ALPORT GLOMERULAR DISEASE

RAC1 INHIBITORS FOR THE TREATMENT OF ALPORT GLOMERULAR DISEASE

Inducible ligand for alpha1beta1 integrin and uses

Treatment of Golmerular Basement Membrane Disease Involving Matrix...

Inducible ligand for alpha1beta1 integrin and uses

Immunodiagnostic determination of usher syndrome type IIA

Use of alpha1beta1 integrin receptor inhibitors and TGF-beta1 inhib...

Use of α1β1 integrin receptor inhibitors and TGF-&#x0...